Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy
Abstract
PURPOSE Simple hysterectomy and pelvic node assessment (SHAPE) is a phase III randomized trial (ClinicalTrials.gov identifier: NCT01658930 ) reporting noninferiority of simple compared with radical hysterectomy for oncologic outcomes in low-risk cervical cancer. This study presents secondary outcomes of sexual health and quality of life (QOL) of the SHAPE trial. METHODS Participants were randomly assigned to receive either radical or simple hysterectomy. Sexual health was assessed up to 36 months postoperatively using the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised and QOL using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and Cervical Cancer-Specific Module (QLQ-CX24) questionnaires. RESULTS Among participants with at least one QOL measure, clinical and pathologic characteristics were balanced and with no differences in preoperative baseline scores for sexual health or QOL between groups. FSFI total score met the cutoff for dysfunction up to 6 months ( P = .02) in the radical hysterectomy group. Group differences favored simple hysterectomy for FSFI subscales: desire and arousal at 3 months ( P ≤ .001) and pain and lubrication up to 12 months ( P ≤ .018). Both groups met the cutoff for sexual distress but was higher in radical hysterectomy at 3 months ( P = .018). For QLQ-CX24, symptom experience was significantly better up to 24 months ( P = .031) and body image better at 3, 24, and 36 months ( P ≤ .01) for simple hysterectomy. Sexual-vaginal functioning was significantly better up to 24 months ( P ≤ .022) and more sexual activity up to 36 months ( P = .024) in the simple hysterectomy arm. Global health status was significantly higher at 36 months for simple hysterectomy ( P = .025). CONCLUSION Simple hysterectomy was associated with lower rates of sexual dysfunction than radical hysterectomy, with a lower proportion of women having sustained sexual-vaginal dysfunction. These results further support the benefit of surgical de-escalation for low-risk cervical cancer.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (20)
Sarah E. Ferguson
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
Lori A. Brotto
Janice Kwon
University of British Columbia, Vancouver, British Columbia, Canada
Vanessa Samouëlian
Gynecologic Oncology, Centre Hospitalier de l’Université de Montréal (CHUM), Centre de Recherche de l’Université de Montréal (CRCHUM), Université de Montréal, Montreal, QC, Canada
Gwenael Ferron
Institut Claudius Regaud, IUCT-Oncopole and GINECO, Toulouse, France
Amandine Maulard
Gustave Roussy Cancer Center, Villejuif, France
Cor de Kroon
Department of Gynaecology, Leiden University Medical Center, Leiden, the Netherlands
Willemien Van Driel
Center for Gynecologic Cancer, Amsterdam, the Netherlands
John Tidy
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
Karin Williamson
Nottingham University Hospitals, Nottingham, United Kingdom
Sven Mahner
LMU University Hospital, Department of Obstetrics and Gynecology, Munich, Germany
Stefan Kommoss
Diakonie-Klinikum Stuttgart Hospital, Stuttgart, Germany
Frederic Goffin
Karl Tamussino
Medical University of Graz, Graz, Austria
Brynhildur Eyjolfsdottir
Oslo University Hospital, Oslo, Norway
Jae-Weon Kim
Department of Obstetrics and Gynecology, Seoul National University, College of Medicine, Seoul, South Korea
Noreen Gleeson
St James' Hospital, Dublin, Ireland
Dongsheng Tu
Canadian Cancer Trials Group, Queen’s University, Kingston, ON, Canada
Lois Shepherd
Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada
Marie Plante
Centre Hospitalier Universitaire de Quebec, L'Hotel-Dieu de Quebec, Quebec, Canada